MedTrace Logo

The Effect of Gabapentin Used as a Preemptive to the Emergence and Development Chronic Neuropathic Pain in Patients After Spinal Cord Trauma

NCT03255330 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2019-03-07

No results posted yet for this study

Summary

Study of the effect of gabapentin used as a preemptive to the emergence and development chronic neuropathic pain in patients after spinal cord trauma

Conditions

  • Chronic Pain Due to Trauma
  • Spinal Cord Injuries

Interventions

DRUG

Gabapentin

Gabapentin will be given approximately 3 months until no chronic neuropathic pain is present

DRUG

Metamizol

Standardized treatment

DRUG

Tramadol

Standardized treatment

Sponsors & Collaborators

  • Masaryk University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-31
Primary Completion
2020-02-29
Completion
2020-08-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03255330 on ClinicalTrials.gov